LeafNLP Demos
Back to explore

Report #2880778

Received Jan 14, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
0.2 yrs
State
MI
Recovered
Unknown
Vaccinated
Jan 5, 2026
Onset
Jan 5, 2026
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.1Z005765IM / RL
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNKZ005765—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

an 8-week-old patient received CAPVAXIVE due to a human error.; This spontaneous report was received from an Administrator / Supervisor (an office manager in a physician's office) and refers to a(n) 8-week-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 05-Jan-2026, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), 0.5 mL, total (0.5ml/once), lot #Z005765, expiration date: 23-Nov-2026, administered for prophylaxis (route and anatomical site were not reported). This 8-week-old patient received Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) due to a human error.